# FDA Inspection 1255006 - Daniel Fred Goodman, M.D. - November 25, 2024

Source: https://www.keypedia.com/records/fda_inspections/daniel-fred-goodman-md/2ed39930-450c-4176-b906-735fc2e3c0c9
Source feed: FDA_Inspections

> FDA Inspection 1255006 for Daniel Fred Goodman, M.D. on November 25, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255006
- Company Name: Daniel Fred Goodman, M.D.
- Inspection Date: 2024-11-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: San Francisco District Office

## Related Documents

- [FDA Inspection 1255006 - 2024-11-25](https://www.keypedia.com/records/fda_inspections/daniel-fred-goodman-md/77de55b0-f05c-4852-807a-a1a240dbb107)
- [FDA Inspection 1159513 - 2021-12-13](https://www.keypedia.com/records/fda_inspections/daniel-fred-goodman-md/936fa295-a792-48b3-9102-1b99c535babc)

Company: https://www.keypedia.com/companies/daniel-fred-goodman-md/75721ae4-0e50-488f-bbb5-22b050bc0249

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df